Inclusion Criteria:  Healthy male adults aged ≥ 20 and ≤ 55 years at screening Subjects who voluntarily decided to participate in the study and provided written consent to follow study compliance requirements after receiving a detailed explanation on this study and fully understanding the information  Exclusion Criteria:  Subjects unable to have the standard meal provided at the study site Subjects who took (the day of taking the last dose) another investigational or bioequivalence study product within 180 days prior to the first dose